These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. From bone biology to clinical outcome: state of the art and future perspectives. Schett G; Saag KG; Bijlsma JW Ann Rheum Dis; 2010 Aug; 69(8):1415-9. PubMed ID: 20650876 [TBL] [Abstract][Full Text] [Related]
9. Risk factors and management of osteoporosis in inflammatory bowel disease. Targownik LE; Bernstein CN; Leslie WD Curr Opin Gastroenterol; 2014 Mar; 30(2):168-74. PubMed ID: 24419292 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of osteoporosis in rheumatic diseases. Sinigaglia L; Varenna M; Girasole G; Bianchi G Rheum Dis Clin North Am; 2006 Nov; 32(4):631-58. PubMed ID: 17288969 [TBL] [Abstract][Full Text] [Related]
11. Rheumatic diseases: the effects of inflammation on bone. Walsh NC; Crotti TN; Goldring SR; Gravallese EM Immunol Rev; 2005 Dec; 208():228-51. PubMed ID: 16313352 [TBL] [Abstract][Full Text] [Related]
12. Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus. Lane NE Nat Clin Pract Rheumatol; 2006 Oct; 2(10):562-9. PubMed ID: 17016482 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Yee CS; Crabtree N; Skan J; Amft N; Bowman S; Situnayake D; Gordon C Ann Rheum Dis; 2005 Jan; 64(1):111-3. PubMed ID: 15608308 [TBL] [Abstract][Full Text] [Related]
14. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. Ogura-Tomomatsu H; Asano K; Tomomatsu K; Miyata J; Ohmori N; Kodama M; Ueda S; Takihara T; Tanaka K; Kamiishi N; Suzuki Y; Fukunaga K; Oguma T; Sayama K; Betsuyaku T COPD; 2012 Aug; 9(4):332-7. PubMed ID: 22489911 [TBL] [Abstract][Full Text] [Related]
15. [Rheumatoid arthritis and bone -periarticular and systemic bone loss-]. Ono K; Ohashi S; Tanaka S Clin Calcium; 2013 Feb; 23(2):249-55. PubMed ID: 23354093 [TBL] [Abstract][Full Text] [Related]
16. Extra-articular manifestations. Mielants H; Van den Bosch F Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S56-61. PubMed ID: 19822047 [TBL] [Abstract][Full Text] [Related]
17. Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases. Buttgereit F; Palmowski A; Bond M; Adami G; Dejaco C Nat Rev Rheumatol; 2024 Jul; 20(7):417-431. PubMed ID: 38831028 [TBL] [Abstract][Full Text] [Related]
18. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis. Goodhand JR; Kamperidis N; Nguyen H; Wahed M; Rampton DS Aliment Pharmacol Ther; 2011 Mar; 33(5):551-8. PubMed ID: 21198706 [TBL] [Abstract][Full Text] [Related]
19. It's the fracture that matters -bone disease in COPD patients. Regan E; Jaramillo J COPD; 2012 Aug; 9(4):319-21. PubMed ID: 22876916 [No Abstract] [Full Text] [Related]